TQ Therapeutics acquires Juno GmbH to support decentralised cell therapy platform - PharmaTimes TQ Therapeutics (TQx) has acquired Juno Therapeutics GmbH, the German subsidiary of Juno Therapeutics, through a share purchase agreement. Juno GmbH was

#TQTherapeutics #TQx #JunoGmbH #JunoTherapeuticsGmbH #IP #licensingagreements #automatedcellandgenetherapyplatform #CGTplatform #extracorporealcelltherapy #ultrashortCGTplatform #celltherapymanufacturing #individualisedtherapies #celltherapy
pharmatimes.com/news/tq-ther...